How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,327 results for

Long-Acting Reversible Contraception

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. Long-acting reversible contraception: subcutaneous depot medroxyprogesterone acetate (DMPA-SC)

Long-acting reversible contraception: subcutaneous depot medroxyprogesterone acetate (DMPA-SC) L Long-acting re ong-acting rev versible contr ersible contraception: aception: subcutaneous depot medro subcutaneous depot medroxyprogesterone xyprogesterone acetate (DMP acetate (DMPA A-SC) -SC) Evidence summary Published: 28 January 2014 nice.org.uk/guidance/esnm31 pathways K Ke ey points from the e y points from the evidence vidence The content of this evidence summary was up-to-date in January (...) that compared subcutaneous and Long-acting reversible contraception: subcutaneous depot medroxyprogesterone acetate (DMPA-SC) (ESNM31) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 19intramuscular administration of DMPA over 2 years with an optional 1-year extension, and also evaluated the effect of DMPA on BMD (Kaunitz et al. 2009); the other 2 studies were 1-year non- comparative studies (Jain et al. 2004

2014 National Institute for Health and Clinical Excellence - Advice

42. Long-acting reversible contraception: levonorgestrel 13.5 mg intrauterine delivery system

Long-acting reversible contraception: levonorgestrel 13.5 mg intrauterine delivery system L Long-acting re ong-acting rev versible contr ersible contraception: aception: le lev vonorgestrel 13.5 onorgestrel 13.5 mg intr mg intrauterine deliv auterine delivery ery system system Evidence summary Published: 4 June 2014 nice.org.uk/guidance/esnm41 pathways K Ke ey points from the e y points from the evidence vidence The content of this evidence summary was up-to-date in June 2014. See summaries (...) in Nelson et al. (2013) (n=1432): 10 pregnancies occurred over 3 years (0.33 pregnancies per 100 woman-years). The contraceptive failure rate was 0.4% in year 1 and 0.9% over 3 years, which is similar to failure rates seen with correct and consistent use of other methods of long- acting reversible contraception. Safety Safety In women using the levonorgestrel 13.5 mg intrauterine system in the study: 8 serious adverse events were reported (0.6%) including 3 ectopic pregnancies and 2 cases of pelvic

2014 National Institute for Health and Clinical Excellence - Advice

43. Condom Use With Long-Acting Reversible Contraception vs Non-Long-Acting Reversible Contraception Hormonal Methods Among Postpartum Adolescents. Full Text available with Trip Pro

Condom Use With Long-Acting Reversible Contraception vs Non-Long-Acting Reversible Contraception Hormonal Methods Among Postpartum Adolescents. Increased use of long-acting reversible contraception (LARC; intrauterine devices [IUDs] and implants) has likely contributed to declining US teenage pregnancy and birth rates, yet sexually transmitted infection (STI) rates among teenagers remain high. While LARC methods are highly effective for pregnancy prevention, they, as with all nonbarrier methods (...) , do not protect against STIs, including HIV. Studies of the general adolescent population suggest condom use is lower among LARC vs non-LARC hormonal methods users (birth control pill, contraceptive patch, vaginal ring, or injection). Despite the high use of LARC among postpartum teenagers, no studies have examined whether condom use differs by contraceptive method in this population.To compare condom use among sexually active postpartum teenagers using LARC vs those using non-LARC hormonal

2019 JAMA pediatrics

44. Shared Negative Experiences of Long-Acting Reversible Contraception and their Influence on Contraceptive Decision-Making: A Multi-Methods Study. Full Text available with Trip Pro

Shared Negative Experiences of Long-Acting Reversible Contraception and their Influence on Contraceptive Decision-Making: A Multi-Methods Study. We explored how negative stories about long-acting reversible contraception (LARC) - defined as a firsthand negative experience with LARC shared directly with the study participant - were involved in participants' decisions about whether to use LARC following abortion, and how counseling affected the influence of negative LARC stories on contraceptive (...) were valued informants; (3) potential side effects were important to LARC decision-making; and (4) positive and negative features of the counseling encounter influenced the effect of negative LARC stories.Negative LARC stories are common among women presenting for abortion at our institution and may influence patient uptake of these methods. Implications This study uses a multi-methods approach to examine the influence of negative stories about long-acting reversible contraception (LARC

2019 Contraception

45. Using the theory of planned behavior and self-identity to explore women's decision-making and intention to switch from combined oral contraceptive pill (COC) to long-acting reversible contraceptive (LARC). Full Text available with Trip Pro

Using the theory of planned behavior and self-identity to explore women's decision-making and intention to switch from combined oral contraceptive pill (COC) to long-acting reversible contraceptive (LARC). \Most college women use the combined oral contraceptive pill (COC) despite more effective long-acting reversible contraceptive (LARC) methods (e.g., IUDs and implant) being available. Resistance to change methods may be impacted by how a woman identifies with being a COC-user.Data were

2019 BMC Women's Health

46. Contraceptive method mix and preference: A focus on long acting reversible contraception in Urban Cameroon. Full Text available with Trip Pro

Contraceptive method mix and preference: A focus on long acting reversible contraception in Urban Cameroon. Meeting targets of the Sustainable Development Goals in the domain of maternal health and the Family Planning 2020 commitments for Cameroon requires an increased use of modern contraception. Long acting reversible contraceptives (LARCs) are methods which have been proven highly efficient with contraceptive failure rates of less than 1%. The objective of this survey was to determine (...) rate of use of LARCs is still very low among these women. The number of living children is significantly associated with the use of LARCs. The local family planning policy makers should intensify sensitization on the benefits and side effects of modern contraception and LARCs in order to create more awareness and improve contraceptive uptake.

2018 PLoS ONE

47. Sickle cell disease: Scenario: Contraception

intrauterine system [LNG-IUS] or copper intrauterine devices [Cu-IUD]). See the CKS topic on for detailed information on these methods of contraception. Surgical sterilization. See the CKS topic on for detailed information on this method of contraception. Barrier methods. See the CKS topic on for detailed information on this method of contraception. However, advise the woman to consider using a long-acting reversible contraception (Cu-IUD, LNG-IUS, progestogen-only injectables, progestogen-only implant (...) consistently and correctly, because of their relatively higher typical-use failure rates [ ]. Advising the woman to consider using a long-acting reversible contraception (LARC) method This recommendation is based on the UK eligibility criteria and the WHO eligibility criteria, which state that the sole use of barrier methods and user-dependent methods of contraception (such as oral contraception) may not be the most appropriate choice for women with conditions that may pose a significant health risk during

2018 NICE Clinical Knowledge Summaries

48. Contraception after surgical abortion

into abortion care and that many are able to provide women with short-acting reversible contraception [85]. However, there are signi?cant barriers to provision of IUDs and implants at many clinics (GRADE 1B)[86,87].In asurveyofNationalAbortion Federation memberfa- cilities, 36% provide immediate postabortion IUDs and 17% provide postprocedureimplants,with thehighestrates notedin states with contraceptive coverage mandates or Medicaid family planning 5 A.H.Roe,D. Bartz/Contraception99(2019)2–9expansion (...) C, Hagbom-Ma C, et al. Impact of a theory-based video on initiation of long-acting reversible contraception after abortion. Am J Obstet Gynecol 2015;212(3):310.31–7 [EvidenceGrade: I]. [27] StewartH,McCallSJ,McPhersonC,TowersLC,LloydB,FletcherJ,etal.Effectiveness of peri-abortion counselling in preventing subsequent unplanned pregnancy: a systematic review of randomised controlled trials. J Fam Plann Reprod Health Care2016;42(1):59–67. [28] Matulich M, Cansino C, Culwell KR, Creinin MD

2018 Society of Family Planning

49. Long-acting reversible contraception acceptability and satisfaction is high among adolescents

Long-acting reversible contraception acceptability and satisfaction is high among adolescents Long-acting reversible contraception acceptability and satisfaction is high among adolescents | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Long-acting reversible contraception acceptability and satisfaction is high among adolescents Article Text Commentary: Maternal and child health Long-acting reversible contraception acceptability

2017 Evidence-Based Medicine

50. Long acting reversible contraception use and associated factors among married women of reproductive age in Nepal. Full Text available with Trip Pro

Long acting reversible contraception use and associated factors among married women of reproductive age in Nepal. Modern contraceptives are highly effective and proven means of preventing unintended pregnancy and reducing maternal mortality. Social and economic characteristics are some of the key determinants of health and utilization family planning. However, studies examining the factors associated with utilization of long acting reversible contraception (LARC) are limited in Nepal

2019 PLoS ONE

51. Contextual influences on the choice of long-acting reversible and permanent contraception in Ethiopia: A multilevel analysis. Full Text available with Trip Pro

LARP methods was significantly lower among adolescents (OR, 0.53; 95% CI, 0.32-0.85) and women over the age of 40 (OR, 0.63; 95% CI, 0.44-0.90) compared to women in their 20's.The findings of this study indicate that the demand for long-acting reversible and permanent contraception is influenced not only by women's individual and household characteristics but also by the community's level of women's empowerment, socio-economic development, as well as access and exposure to family planning (...) Contextual influences on the choice of long-acting reversible and permanent contraception in Ethiopia: A multilevel analysis. Long acting reversible and permanent contraception (LARPs) offer promising opportunities for addressing the high and growing unmet need for modern contraception and helps to reduce unintended pregnancies and abortion rates in sub-Saharan Africa (SSA). This study examines the contextual factors that influence the use of long acting reversible and permanent contraception

2019 PLoS ONE

52. Trends, patterns and determinants of long-acting reversible methods of contraception among women in sub-Saharan Africa. Full Text available with Trip Pro

Trends, patterns and determinants of long-acting reversible methods of contraception among women in sub-Saharan Africa. Method-specific contraceptive prevalence varies widely globally, as huge variations exist in the use of different types of contraception, with short-term methods being the most common methods in sub-Saharan Africa (SSA). Evidence is scanty on the trends, patterns and determinants of long-acting reversible contraceptive (LARC) methods in SSA. This study aimed to address (...) this knowledge gap.Using a pseudo longitudinal research design and descriptive and inferential statistics, we analysed Demographic and Health Survey data of eight countries selected on the basis of contraceptive prevalence rates across SSA. Multinomial logistic regression modelling was used to tease out the predictors of the uptake of LARC methods in the selected countries.Findings exhibit a steady but slow upward trend in LARC methods across selected countries, as a marginal increase was recorded in LARC

2019 PLoS ONE

53. Long-Acting Reversible Contraception: Implants and Intrauterine Devices

Long-Acting Reversible Contraception: Implants and Intrauterine Devices Long-Acting Reversible Contraception: Implants and Intrauterine Devices - ACOG Menu ▼ Long-Acting Reversible Contraception: Implants and Intrauterine Devices Page Navigation ▼ Number 186, November 2017 (Replaces Practice Bulletin Number 121, July 2011) Committee on Practice Bulletins—Gynecology . This Practice Bulletin was developed by the Committee on Practice Bulletins—Gynecology and the Long-Acting Reversible (...) , incurred in connection with this publication or reliance on the information presented. Long-Acting Reversible Contraception: Implants and Intrauterine Devices Intrauterine devices and contraceptive implants, also called long-acting reversible contraceptives (LARC), are the most effective reversible contraceptive methods. The major advantage of LARC compared with other reversible contraceptive methods is that they do not require ongoing effort on the part of the patient for long-term and effective use

2017 American College of Obstetricians and Gynecologists

54. The Zika Contraception Access Network: a feasibility programme to increase access to contraception in Puerto Rico during the 2016–17 Zika virus outbreak Full Text available with Trip Pro

for the Centers for Disease Control and Prevention (CDCF) secured a supply of reversible contraceptive methods (including long-acting reversible contraception), made available to non-sterilised women of reproductive age at no cost through provider reimbursements and infrastructure supported by the CDCF. To build capacity in contraception service provision, doctors and clinic staff from all public health regions and nearly all municipalities in Puerto Rico were recruited into the programme. All providers (...) completed 1 day of comprehensive training in contraception knowledge, counselling, and initiation and management, including the insertion and removal of long-acting reversible contraceptives (LARCs). Z-CAN was announced through health-care providers, word of mouth, and a health education campaign. Descriptive characteristics of programme providers and participants were recorded, and we estimated the factors associated with choosing and receiving a LARC method. As part of a Z-CAN programme monitoring

2018 The Lancet. Public health

55. Immediate Postpartum Long-Acting Reversible Contraception

Immediate Postpartum Long-Acting Reversible Contraception Immediate Postpartum Long-Acting Reversible Contraception - ACOG Menu ▼ Immediate Postpartum Long-Acting Reversible Contraception Page Navigation ▼ Number 670, August 2016 (Reaffirmed 2018) Committee on Obstetric Practice The American College of Nurse–Midwives and the Society for Maternal–Fetal Medicine endorse this document. The American Academy of Family Physicians and the Association of Women’s Health, Obstetric and Neonatal Nurses (...) support this document. This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice in collaboration with committee members Ann E. Borders, MD, MSc, MPH and Alison M. Stuebe, MD, MSc, and reviewed by the Long-Acting Reversible Contraception Work Group. This document reflects emerging clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course

2016 American College of Obstetricians and Gynecologists

56. Clinical Challenges of Long-Acting Reversible Contraceptive Methods

Clinical Challenges of Long-Acting Reversible Contraceptive Methods Clinical Challenges of Long-Acting Reversible Contraceptive Methods - ACOG Menu ▼ Clinical Challenges of Long-Acting Reversible Contraceptive Methods Page Navigation ▼ Number 672, September 2016 (Reaffirmed 2019) Committee on Gynecologic Practice Long-Acting Reversible Contraception Work Group This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Gynecologic Practice (...) and the Long-Acting Reversible Contraceptive Expert Work Group in collaboration with committee member David L. Eisenberg, MD, and Expert Work Group members Nichole Tyson, MD and Eve Espey, MD. This document reflects emerging clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Clinical Challenges of Long-Acting Reversible Contraceptive Methods ABSTRACT: Long-acting

2016 American College of Obstetricians and Gynecologists

57. Cohort study: Oral contraceptives do not appear to present long-term cancer harms and may even provide protection against some cancers

prescribe combined oral contraceptive (COCs) and counsel patients about COCs are in a position to ensure balanced discussion as they improve patient knowledge of known benefits and risks. Prescribers presenting health teaching should have an equal focus on the benefits and risks. Future research should include side-by-side comparisons of COCs and other types of fertility control (ie, long-acting reversible contraceptives and/or vaginal rings) to provide women with the evidence needed to make informed (...) Cohort study: Oral contraceptives do not appear to present long-term cancer harms and may even provide protection against some cancers Oral contraceptives do not appear to present long-term cancer harms and may even provide protection against some cancers | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log

2018 Evidence-Based Nursing

58. Mental health diagnoses and early removal of long-acting reversible contraception. (Abstract)

Mental health diagnoses and early removal of long-acting reversible contraception. Having a mental health diagnosis is associated with contraceptive non-adherence and user-related contraceptive failures of short-acting methods. There is a lack of research on the relationship between mental health diagnoses and early discontinuation of highly effective long-acting reversible (LARC) methods such as the intrauterine device (IUD) and subdermal implant (SDI).Using a Primary Care and Obstetrics (...) timing of removal.Understanding why women choose early LARC removal can inform counseling to help women make informed choices about their contraceptive method that meets their reproductive needs.Copyright © 2019. Published by Elsevier B.V.

2020 Journal of Affective Disorders

59. Patient perceptions of immediate postpartum long-acting reversible contraception: A qualitative study. Full Text available with Trip Pro

Patient perceptions of immediate postpartum long-acting reversible contraception: A qualitative study. The objective of this study was to explore perceptions and experiences of immediate postpartum long-acting reversible contraception (LARC) counseling and decision-making, with a focus on reproductive autonomy. We aimed to assess the potential for reproductive coercion.This was a qualitative study using semi-structured interviews with Spanish and English speaking women who received (...) an intrauterine device or contraceptive subdermal implant immediately postpartum. They were recruited before discharge from two hospitals in Baltimore, MD. We analyzed interviews using directed content analysis.We interviewed a diverse group of 17 women. Participants praised the convenience of LARC and the ease of immediate postpartum placement. Some women reported feeling pushed by providers during counseling and were critical of their experiences. Women expressed a desire for comprehensive, objective

2020 Contraception

60. Long-Acting Reversible Contraception Free-of-Charge: Two-year Discontinuation, its Risk Factors and Reasons. (Abstract)

Long-Acting Reversible Contraception Free-of-Charge: Two-year Discontinuation, its Risk Factors and Reasons. Since 2013, the residents of the city of Vantaa, Finland, have been offered their first long-acting reversible contraceptive method (levonorgestrel-releasing intrauterine system, implant, and copper intrauterine device) free-of-charge.The primary aim was to assess the two-year cumulative discontinuation rates of long-acting reversible contraceptive methods when provided free-of-charge (...) for first-time users in a real-world setting. Additional aims were to describe factors associated with discontinuation, and to evaluate the reasons for discontinuation.This is a retrospective register-based cohort study of all 2026 non-sterilized women aged 15-44 years, who initiated a long-acting contraceptive method free-of-charge in 2013-2014 in the city of Vantaa. Removals within two years after method initiation and reasons for discontinuation were obtained from electronic health records and from

2020 American Journal of Obstetrics and Gynecology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>